Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.51M Sell
17,917
-331
-2% -$71.2K 0.09% 112
2026
Q1
$3.97M Sell
18,248
-656
-3% -$146K 0.09% 109
2025
Q4
$4.32M Sell
18,904
-28,110
-60% -$6.4M 0.09% 106
2025
Q3
$10.9M Sell
47,014
-1,090
-2% -$222K 0.26% 54
2025
Q2
$9.04M Buy
48,104
+4,094
+9% +$761K 0.23% 61
2025
Q1
$9.22M Sell
44,010
-17,935
-29% -$3.49M 0.24% 49
2024
Q4
$10.9M Sell
61,945
-6,590
-10% -$1.21M 0.26% 47
2024
Q3
$13.5M Buy
68,535
+11,465
+20% +$2.14M 0.33% 40
2024
Q2
$9.79M Sell
57,070
-20,074
-26% -$3.33M 0.26% 49
2024
Q1
$14M Buy
77,144
+51
+0.1% +$8.79K 0.39% 30
2023
Q4
$11.9M Buy
+77,093
New +$11.2M 0.37% 35

Other funds holding ABBV

AlTi Global's ABBV Position: Q2 2026 in Review

AlTi Global reduced its AbbVie (ABBV) stake by 1.8% in Q2 2026, selling an estimated $71.2K and leaving 17,917 shares worth $4.51M. The position accounts for 0.09% of the portfolio, ranked #112.

AlTi Global first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $14M in Q1 2024. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AlTi Global held 17,917 shares of AbbVie worth $4.51M as of Q2 2026.
  • AlTi Global sold 331 AbbVie shares in Q2 2026, an estimated $71.2K.
  • AbbVie made up 0.09% of AlTi Global's portfolio in Q2 2026, its #112 holding.
  • AlTi Global first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • AlTi Global's AbbVie position peaked at $14M in Q1 2024.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.